Clinical Trials Browser

OTHER × Neoplasms × Topotecan × Clear all

NCT05421897 2026-01-29

RAPID

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT04947501 2025-08-05

A Study of N9 Chemotherapy in Children With Neuroblastoma

Phase EARLY_PHASE1 Active not recruiting

Neoplasms, Neuroblastoma

NCT02500459 2019-03-01

Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Glioma, Neoplasms

NCT01683149 2016-03-04

Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies

Phase 1 Completed

Neoplasms, Recurrence

NCT00382733 2013-07-22

Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

Phase 1/2 Completed

26 enrolled 8 charts

Neoplasms

NCT00250094 2011-09-07

Clinical Benefit of Topoisomerase Downregulation

Phase 1 Completed

Neoplasms, Ovarian Neoplasms

NCT00429559 2011-07-22

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Phase 1/2 Completed

Neoplasms, Ovarian Neoplasms

NCT00193583 2011-05-04

Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00320983 2010-01-07

Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer

Phase 1 Completed

Uterine Cervical Neoplasms, Neoplasms

NCT00412503 2009-08-07

Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

Phase 1 Completed

Neoplasms

NCT00888810 2009-04-28

TOPO-LAPA

Phase 2 Terminated

Neoplasms, Recurrence

NCT00193570 2009-01-23

Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00135135 2008-06-03

Therapy for Children With Neuroblastoma

Phase 2 Completed

Neoplasms, Neuroblastoma